Related Experiment Videos
Glycaemic control and weight loss with semaglutide in type 2 diabetes
1Department of Endocrinology, Hvidovre Hospital, University of Copenhagen, 2650 Hvidovre, Denmark; NNF Center for Basic Metabolic Research and Department of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
The Lancet. Diabetes & Endocrinology
|April 8, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.
The Journal of clinical endocrinology and metabolism·2019
Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls.
The American journal of clinical nutrition·2019
Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.
The lancet. Diabetes & endocrinology·2026
From adiposity to multisystem morbidity: the case for weight loss as disease modification.
The lancet. Diabetes & endocrinology·2026
Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.
The lancet. Diabetes & endocrinology·2026
Beyond Compensation: Hyperinsulinemia as an Early Driver of Cardiovascular-Kidney-Metabolic Syndrome.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026